Du er her: AU »
Om AU »
Organisation
» ANTI-GALECTIN-9 ANTIBODY AS A NOVEL TREATMENT OPTION IN R...
ANTI-GALECTIN-9 ANTIBODY AS A NOVEL TREATMENT OPTION IN RHEUMATOID ARTHRITIS TARGETING PATHOGENIC FIBROBLAST-LIKE SYNOVIOCYTES Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review
Ditte Koster, Aarhus Universitet , Malene Hvid Aida Solhoj Hansen Tue Wenzel Kragstrup Pierre Busson, Univ Paris Saclay, Universite Paris Saclay, Universite Paris Sud - Paris 11, Universite Paris Saclay (ComUE), Centre National de la Recherche Scientifique (CNRS), Ecole Normale Superieure Paris-Saclay, CNRS, ENS Paris Saclay, Lab Aime Cotton,Univ Paris Sud , Bent Deleuran Morten Aagaard Nielsen Originalsprog Engelsk Udgivelsesår jun. 2019 Antal sider 2 DOI Status Udgivet - jun. 2019 Eksternt udgivet Ja Begivenhed Annual European Congress of Rheumatology (EULAR) - Madrid, Spanien Varighed: 12 jun. 2019 → 15 jun. 2019
Konference Annual European Congress of Rheumatology (EULAR) Land Spanien By Madrid Periode 12/06/2019 → 15/06/2019
Se relationer på Aarhus Universitet
Citationsformater
ID: 188932636
Aarhus Universitet
Nordre Ringgade 1
8000 Aarhus
Email: au@au.dk
Tlf: 8715 0000
CVR-nr: 31119103
EORI-nummer: DK-31119103
EAN-numre: www.au.dk/eannumre